1. Home
  2. DRIO

as 11-21-2024 3:34pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Founded: 2011 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 25.1M IPO Year: N/A
Target Price: $4.00 AVG Volume (30 days): 61.5K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.88 EPS Growth: N/A
52 Week Low/High: $0.70 - $2.60 Next Earning Date: 11-07-2024
Revenue: $23,052,000 Revenue Growth: -2.09%
Revenue Growth (this year): 36.66% Revenue Growth (next year): 35.35%

DRIO Daily Stock ML Predictions

Stock Insider Trading Activity of DarioHealth Corp. (DRIO)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Nelson Steven Charles DRIO Chief Commercial Officer Sep 10 '24 Buy $0.82 10,000 $8,243.50 45,000
Nelson Steven Charles DRIO Chief Commercial Officer Sep 5 '24 Buy $0.82 15,000 $12,291.50 45,000
Raphael Erez DRIO Chief Executive Officer Aug 27 '24 Buy $0.88 5,000 $4,400.00 1,937,059

Share on Social Networks: